Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1992 Oct;76(10):578–581. doi: 10.1136/bjo.76.10.578

The red eye of renal failure: a crystal induced inflammation?

N Klaassen-Broekema 1, O P van Bijsterveld 1
PMCID: PMC505218  PMID: 1420037

Abstract

Of 57 patients with chronic renal failure and calcification of the anterior membranes of the eye eight developed inflammatory reactions, clinically indistinguishable from pingueculitis. In three patients an acute inflammatory reaction of the episcleral tissue and the conjunctiva over it developed which we considered to represent the red eye of renal failure. In these patients massive shedding of calcium phosphate salts was clinically evident. Histopathologically in all these patients calcific deposits were observed. Although sporadically polymorphonuclear leucocytes were present in the inflamed tissues we could not demonstrate crystal phagocytosis. We believe that in the red eyes in renal failure and, more specifically, in the red eyes of renal failure a crystal induced inflammatory mechanism is not operative.

Full text

PDF
578

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berkow J. W., Fine B. S., Zimmerman L. E. Unusual ocular calcification in hyperparathyroidism. Am J Ophthalmol. 1968 Nov;66(5):812–824. doi: 10.1016/0002-9394(68)92795-5. [DOI] [PubMed] [Google Scholar]
  2. Berlyne G. M. Microcrystalline conjunctival calcification in renal failure. A useful clinical sign. Lancet. 1968 Aug 17;2(7564):366–370. doi: 10.1016/s0140-6736(68)90590-4. [DOI] [PubMed] [Google Scholar]
  3. Berlyne G. M., Shaw A. B. Red eyes in renal failure. Lancet. 1967 Jan 7;1(7480):4–7. doi: 10.1016/s0140-6736(67)92418-x. [DOI] [PubMed] [Google Scholar]
  4. Bjelle A. O. Morphological study of articular cartilage in pyrophosphate arthropathy. (Chondrocalcinosis articularis or calcium pyrophosphate dihydrate crystal deposition diseases). Ann Rheum Dis. 1972 Nov;31(6):449–456. doi: 10.1136/ard.31.6.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brandt K. D. The effect of synovial hyaluronate on the ingestion of monosodium urate crystals by leukocytes. Clin Chim Acta. 1974 Sep 30;55(3):307–315. doi: 10.1016/0009-8981(74)90004-7. [DOI] [PubMed] [Google Scholar]
  6. Ginsberg M. H., Kozin F., Chow D., May J., Skosey J. L. Adsorption of polymorphonuclear leukocyte lysosomal enzymes to monosodium urate crystals. Arthritis Rheum. 1977 Nov-Dec;20(8):1538–1542. doi: 10.1002/art.1780200815. [DOI] [PubMed] [Google Scholar]
  7. Klaassen-Broekema N., van Bijsterveld O. P. Red eyes in renal failure. Br J Ophthalmol. 1992 May;76(5):268–271. doi: 10.1136/bjo.76.5.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. MCCARTY D. J., Jr, GATTER R. A., BRILL J. M., HOGAN J. M. CRYSTAL DEPOSITION DISEASES: SODIUM URATE (GOUT) AND CALCIUM PYROPHOSPHATE (CHONDROCALCINOSIS, PSEUDOGOUT). JAMA. 1965 Jul 12;193:129–132. doi: 10.1001/jama.1965.03090020043011. [DOI] [PubMed] [Google Scholar]
  9. Maurer K. H., Schumacher H. R. Hydroxyapatite phagocytosis by human polymorphonuclear leucocytes. Ann Rheum Dis. 1979 Feb;38(1):84–88. doi: 10.1136/ard.38.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McCarty D. J., Jr, Gatter R. A. Recurrent acute inflammation associated with focal apatite crystal deposition. Arthritis Rheum. 1966 Dec;9(6):804–819. doi: 10.1002/art.1780090608. [DOI] [PubMed] [Google Scholar]
  11. SOKOLOFF L. The pathology of gout. Metabolism. 1957 May;6(3):230–243. [PubMed] [Google Scholar]
  12. Terkeltaub R. A., Santoro D. A., Mandel G., Mandel N. Serum and plasma inhibit neutrophil stimulation by hydroxyapatite crystals. Evidence that serum alpha 2-HS glycoprotein is a potent and specific crystal-bound inhibitor. Arthritis Rheum. 1988 Sep;31(9):1081–1089. doi: 10.1002/art.1780310901. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES